The Postantibiotic Effect

Abstract

Editorials1 June 1987The Postantibiotic EffectWILLIAM A. CRAIG, M.D., BENNETT VOGELMAN, M.D.WILLIAM A. CRAIG, M.D., BENNETT VOGELMAN, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-6-900 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSuppression of bacterial growth that persists after short exposure of organisms to antimicrobial agents has been seen since early investigations with penicillin. For example, Parker and Luse (1) showed in 1948 that staphylococci exposed to penicillin G for 20 minutes and then transferred to drug-free broth did not resume normal growth for 1 to 3 hours. These findings were applied to studies with antituberculous drugs (2), but not until the past decade were they extended to antimicrobial drugs developed after penicillin and to gram-negative bacilli (3, 4). The termpostantibiotic effecthas been used to describe this phenomenon because it...References1. PARKERLUSE RS. The action of penicillin on staphylococcus: further observations on the effect of a short exposure. J Bacteriol. 1948;56:75-81. CrossrefMedlineGoogle Scholar2. BEGGSJENNE WJ. Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures. Tubercle. 1969;50:377-85. CrossrefMedlineGoogle Scholar3. MCDONALDCRAIGKUNIN PWC. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis. 1977;135:217-23. CrossrefMedlineGoogle Scholar4. BUNDTZENGERBERCOHNCRAIG RADW. Postantibiotic suppression of bacterial growth. Rev Infect Dis. 1981;3:28-37. CrossrefMedlineGoogle Scholar5. CRAIGGUDMUNDSSON WS. The postantibiotic effect. In: LORIAN V, ed. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore: William & Wilkins; 1986:515-36. Google Scholar6. TÄUBERZAKSHELDHENGSTLERSANDE MOWBM. The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis. 1984;149:575-83. CrossrefMedlineGoogle Scholar7. INGERMANPITSAKISROSENBERGLEVISON MPAM. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. J Infect Dis. 1986;153:707-14. CrossrefMedlineGoogle Scholar8. KAPUSNIKGORDINSCOTTHACKBARTHSANDE JFKCM. Efficacy of once daily versus conventional aminoglycoside therapy for experimental pseudomonas pneumonia [Abstract]. Clin Res. 1985;33:57A. Google Scholar9. VOGELMANCRAIG BW. Postantibiotic effects. J Antimicrob Chemother. 1985;15(suppl A):37-46. CrossrefMedlineGoogle Scholar10. GUDMUNDSSONVOGELMANCRAIG SBW. The in vivo postantibiotic effect of imipenem and other new antimicrobials. J Antimicrob Chemother. 1986;18(suppl E):67-73. CrossrefMedlineGoogle Scholar11. CRAIGMATTIE WH. Postantibiotic effect (PAE) with Bacteroides fragilis[Abstract]. In: Program and Abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans: American Society for Microbiology; 1986:122. Google Scholar12. MCDONALDWETHERALLPRUUL PBH. Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Rev Infect Dis. 1981;3:38-44. CrossrefMedlineGoogle Scholar13. TUOMANEN E. Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors. J Bacteriol. 1986;167:535-43. CrossrefMedlineGoogle Scholar14. VOGELMANCRAIG BW. Kinetics of antimicrobial activity. J Pediatr. 1986;108(5 pt 2):835-40. CrossrefMedlineGoogle Scholar15. GERBERCRAIGBRUGGERFELLERVASTOLABRANDEL AWHCAJ. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosain granulocytopenic mice. J Infect Dis. 1983;147:910-7. CrossrefMedlineGoogle Scholar16. POWELLTHOMPSONLUTHE SWM. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis. 1983;147:918-32. CrossrefMedlineGoogle Scholar17. FELDVALDIVIESOBODEYRODRIGUEZ RMGV. A comparative trial of sisomicin therapy by intermittent versus continuous infusion. Am J Med Sci. 1977;274:179-88. CrossrefMedlineGoogle Scholar18. NORDSTROMCRONBERGRINBERGTRENSTROMWALDER LSHOM. Prospective, comparative, randomized clinical study of aminoglycosides given once a day versus three times a day in severe infections. In: ISHIGAMI J, ed. Recent Advances in Chemotherapy. Tokyo: University of Tokyo Press; 1985:2653-4. Google Scholar19. ROOSENDAALBAKKER-WOUDENBERGVAN DEN BERGMICHEL RIJM. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J Infect Dis. 1985;152:373-8. CrossrefMedlineGoogle Scholar20. BODEYKETCHELRODRIGUEZ GSV. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med. 1979;67:608-16. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: William S. Middleton Memorial Veterans Hospital University of Wisconsin Madison, Wisconsin PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPostantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureusNanostructured biomedical selenium at the biological interface (Review)Drug detoxification dynamics explain the postantibiotic effectPharmacology of Drug ResistanceIn Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum SizesPredictors of Monomicrobial Necrotizing Soft Tissue InfectionsPrise en charge des infections invasives et graves à streptocoque du groupe APentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosisPostantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickensAminoglycosidesAntimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic ConsiderationsInvasive Group A Streptococcal DiseaseA Case of Toxic Shock-like Syndrome with Soft Tissue Necrosis on FaceClinical Experience with Aminoglycosides in Dialysis-Dependent Patients: Risk Factors for Mortality and Reassessment of Current Dosing PracticesSource of Phosphate in the Enzymic Reaction as a Point of Distinction among Aminoglycoside 2″-PhosphotransferasesPlasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacinObservational Trial of a 48-Hour Gentamicin Dosing Regimen Derived from Monte Carlo Simulations in Infants Born at Less than 28 Weeks' GestationDiagnosis and treatment of invasive group A streptococcal infectionsToxin-Mediated Diseases and Toxic Shock SyndromeAminoglycosidesGlycopeptide PharmacodynamicsModeling In Vivo Pharmacokinetics and Pharmacodynamics of Moxifloxacin Therapy for Mycobacterium tuberculosis Infection by Using a Novel Cartridge SystemCurrent use for old antibacterial agents: polymyxins, rifampin, and aminoglycosidesValidation of a Simplified Netilmicin Dosage Regimen in InfantsAntimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microfloraRationale and utility of therapeutic drug monitoring for the optimization of antibiotic therapyVersatility of Aminoglycosides and Prospects for Their FutureIn Vivo Antibacterial Activity of RWJ-54428, a New Cephalosporin with Activity against Gram-Positive BacteriaThe antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditionsExtended interval aminoglycoside dosing: from concept to clinicPharmacokinetics of Intraperitoneal Cefazolin and Gentamicin in Empiric Therapy of Peritonitis in Continuous Ambulatory Peritoneal Dialysis PatientsSingle-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancerNew developments and concepts in antimicrobial therapy for intra-abdominal infectionsONCE-DAILY DOSING OF AMINOGLYCOSIDE ANTIBIOTICSWhat is the evidence for effective treatment of diabetic foot ulceration?Letters to the EditorOuter Membrane Proteins of Klebsiella pneumoniae After Exposure to CiprofloxacinFlow Cytometric Assessment of the Postantibiotic Effect of Methicillin on Staphylococcus aureusUse of antibiotics in patients receiving intensive careA comparison of two amikacin dosing regimens in paediatric surgical patientsPharmacokinetics of once-daily dosing of gentamicin in neonatesOnce daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancerThe population dynamics of antimicrobial chemotherapyTherapeutic Drug Monitoring of Therapy for Infectious DiseasesPostantibiotic Effect and Virulence Factors Depression Induced by Ciprofloxacin and by Aminoglycosides in a Clinical Isolate of Pseudomonas aeruginosaPharmacokinetic principles of antimicrobial therapyEfficacy and Safety of Once-Daily Amikacin in Combination with Ceftazidime in Critically Ill Adults with Severe Gram-Negative InfectionsANTIBACTERIAL AGENTS IN RENAL FAILUREAminoglycosides: The complex problem of antibiotic mechanisms and clinical applicationsJournal of Pharmacy PracticeTherapeutic Drug Monitoring of Therapy for Infectious DiseasesParenteral versus oral antibiotic therapyImproved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitroPreclinical and Clinical Evaluation of Once-Daily Aminoglycoside ChemotherapyPharmacoeconomic Evaluation of Once-Daily Aminoglycoside TreatmentAminoglycoside dosing: time to changeIn vitro suppression ofPseudomonas cepacia after limited exposure to subinhibitory concentrations of amiloride and 5-(N,N-hexamethylene) amilorideOptimal adaptive control of pharmacodynamic effects with aminoglycoside antibiotics: A required approach for the futureNecrotising fasciitisRenal Handling of Tobramycin in the Isolated Perfused Rat KidneyOnce daily dosing of netilmicin in neonatal and pediatric intensive carePharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacinFever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokineticsL'amikacine administrée en dose unique journalière. Les arguments bactériologiquesInfluence of therapeutic plasmapheresis on elimination of ceftiaxoneSelecting the AntibioticAntimicrobial Prophylaxis in Surgery: Mechanisms, Misconceptions, and MischiefEvaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection modelAntimicrobial Prophylaxis in Surgery: Mechanisms, Misconceptions, and MischiefPharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelSimplified dosing and monitoring of vancomycin for the burn care clinicianAdaptive resistance following single doses of gentamicin in a dynamic in vitro modelEffect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coliPenetration of Netilmicin in the Lower Respiratory Tract after Once-Daily DosingPrevention and Management of Infective EndocarditisEvaluation of synergistic effects of combinations of antibacterials having relevance to treatment of burn wound infections9 Infections in the compromised childOnce-daily aminoglycoside therapyThe Postantibiotic Effect: A Review of in Vitro and in Vivo DataAminoglycoside-induced renal phospholipidosis and nephrotoxicityGeneral Principles of Therapy of Pyogenic MeningitisOverview of Infectious Diseases, Part 2Pharmacodynamics of Antibiotics-Consequences for Dosing: Proceedings of a Symposium Held in Stockholm, June 7–9, 1990Once-daily dosing regimen for aminoglycoside plus β-Lactam combination therapy of serious bacterial infections: Comparative trial with netilmicin plus ceftriaxoneQuantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamstersPharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen DesignGentamicin volume of distribution in critically ill septic patientsImpact of dosage schedule of antibiotics on the treatment of serious infectionsClinical predictive value of in vitro susceptibility testsComments on the optimal use of aminoglycosidesImpact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin inKlebsiella pneumoniae pneumonia and septicemia in leukopenic ratsAlternative Dosing Strategy for Aminoglycosides: Impact on Efficacy, Nephrotoxicity, and OtotoxicityOnce-daily aminoglycoside administration: New strategies for an old drugUse of Antimicrobial Agents in Renal FailureIn vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strainsInfluence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbitsAminoglycoside Nephrotoxicity: Mechanism and PreventionEDITORIAL REVIEW: MECHANISMS OF AMINOGLYCOSIDE NEPHROTOXICITYTherapeutic Update on Glycopeptide and Lipopeptide AntibioticsPrinciples of Antimicrobial Therapy for Head and Neck InfectionsCausation and Management of Microbial Keratitis in Subtropical AfricaPharmacologic considerations with antimicrobials used in oncology 1 June 1987Volume 106, Issue 6Page: 900-902KeywordsAntimicrobialsDrugsPenicillin Issue Published: 1 June 1987 PDF downloadLoading ...